Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Nipple fluid for breast cancer diagnosis using the nanopore of Phi29 DNA-packaging motor.
Journal: Nanomedicine : nanotechnology, biology, and medicine
Published: September 28, 2022
BTK inhibition potentiates anti-PD-L1 treatment in murine melanoma: potential role for MDSC modulation in immunotherapy.
Journal: Cancer immunology, immunotherapy : CII
Published: July 26, 2022
Expression Patterns of microRNAs and Associated Target Genes in Ulcerated Primary Cutaneous Melanoma.
Journal: The Journal of investigative dermatology
Published: May 04, 2021
Bruton's tyrosine kinase: an emerging targeted therapy in myeloid cells within the tumor microenvironment.
Journal: Cancer immunology, immunotherapy : CII
Published: October 12, 2020
Observations on the use of Bruton's tyrosine kinase inhibitors in SAR-CoV-2 and cancer.
Journal: Journal of hematology & oncology
Published: October 06, 2020
NCCN Guidelines Insights: Uveal Melanoma, Version 1.2019.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: February 06, 2020
Emerging roles of and therapeutic strategies targeting BRD4 in cancer.
Journal: Cellular immunology
Published: January 17, 2019
Generation of monocyte-derived tumor-associated macrophages using tumor-conditioned media provides a novel method to study tumor-associated macrophages in vitro.
Journal: Journal for immunotherapy of cancer
Published: November 02, 2018
A Phase I/II Trial of Cetuximab in Combination with Interleukin-12 Administered to Patients with Unresectable Primary or Recurrent Head and Neck Squamous Cell Carcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 12, 2018
A pilot study of interferon-alpha-2b dose reduction in the adjuvant therapy of high-risk melanoma.
Journal: Cancer immunology, immunotherapy : CII
Published: June 01, 2018
Author Correction: Nitric oxide mediated inhibition of antigen presentation from DCs to CD4+ T cells in cancer and measurement of STAT1 nitration.
Journal: Scientific reports
Published: March 08, 2018
Identification of NRAS isoform 2 overexpression as a mechanism facilitating BRAF inhibitor resistance in malignant melanoma.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 23, 2017
Last Updated: 09/26/2026